Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
21.24
+0.24 (1.14%)
Apr 28, 2026, 10:54 AM EDT - Market open
Syndax Pharmaceuticals Employees
Syndax Pharmaceuticals had 298 employees as of December 31, 2025. The number of employees increased by 28 or 10.37% compared to the previous year.
Employees
298
Change (1Y)
28
Growth (1Y)
10.37%
Revenue / Employee
$578,362
Profits / Employee
-$957,792
Market Cap
1.87B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 298 | 28 | 10.37% | 298 | 0 |
| Dec 31, 2024 | 270 | 86 | 46.74% | 270 | 0 |
| Dec 31, 2023 | 184 | 77 | 71.96% | 184 | 0 |
| Dec 31, 2022 | 107 | 48 | 81.36% | 107 | 0 |
| Dec 31, 2021 | 59 | 16 | 37.21% | 59 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Recursion Pharmaceuticals | 600 |
| Galapagos NV | 558 |
| Vericel | 398 |
| Harmony Biosciences Holdings | 293 |
| Stoke Therapeutics | 170 |
| Pharvaris | 129 |
| Inhibrx Biosciences | 110 |
| Taysha Gene Therapies | 99 |
SNDX News
- 4 days ago - Syndax to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on April 30, 2026 - GlobeNewsWire
- 24 days ago - Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Syndax Pharmaceuticals Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 6 weeks ago - Syndax Pharmaceuticals Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Syndax Pharmaceuticals Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Syndax Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Syndax Announces Participation in March Investor Conferences - GlobeNewsWire